Combination of lenalidomide and rituximab in treatment of the elderly patients with initially treated or relapsed and refractory B-cell non-Hodgkin’s lymphoma: clinical efficacy and safety

ZHENG Hong, CHU Yudan, ZHU Zihua

PDF(746 KB)
Tumor website：www.tumorsci.org E-mail Alert
PDF(746 KB)
Tumor ›› 2022, Vol. 42 ›› Issue (11) : 744-749. DOI: 10.3781/j.issn.1000-7431.2022.2206-0455
Original Research

Combination of lenalidomide and rituximab in treatment of the elderly patients with initially treated or relapsed and refractory B-cell non-Hodgkin’s lymphoma: clinical efficacy and safety

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 42(11): 744-749 https://doi.org/10.3781/j.issn.1000-7431.2022.2206-0455

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(746 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Tumor, All Rights Reserved.
E-mail: tumor@tumorsci.org
Powered by Beijing Magtech Co., Ltd.

/

〈 〉